Clinical Trial Update: Pyridostigmine and Amifampridine for Myasthenia Gravis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for pyridostigmine and amifampridine in myasthenia gravis is in UNKNOWN status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Amifampridine (amifampridine)
• Pyridostigmine (pyridostigmine)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Myasthenia Gravis | Phase 3 | Status: UNKNOWN